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Abstract Recent advances in genome editing technologies
have enabled the rapid and precise manipulation of genomes,
including the targeted introduction, alteration, and removal of
genomic sequences. However, respective methods have been
described mainly in non-differentiated or haploid cell types.
Genome editing of well-differentiated renal epithelial cells has
been hampered by a range of technological issues, including
optimal design, efficient expression of multiple genome
editing constructs, attainable mutation rates, and best screen-
ing strategies. Here, we present an easily implementable
workflow for the rapid generation of targeted heterozygous
and homozygous genomic sequence alterations in renal cells
using transcription activator-like effector nucleases (TALENs)
and the clustered regularly interspaced short palindromic
repeat (CRISPR) system. We demonstrate the versatility of
established protocols by generating novel cellular models for
studying autosomal dominant polycystic kidney disease
(ADPKD). Furthermore, we show that cell culture-validated
genetic modifications can be readily applied to mouse embry-
onic stem cells (mESCs) for the generation of corresponding
mouse models. The described procedure for efficient genome
editing can be applied to any cell type to study physiological
and pathophysiological functions in the context of precisely
engineered genotypes.
Keywords CRISPR .TALEN .MDCK .mIMCD3 . PKD1 .
PKD2
Introduction
Analyses of epithelial physiology in genetically tractable
model organisms have provided important biological insights.
However, the complex interaction of multiple cell types and
finite experimental resolution of specific cellular functions
within tissues have made complementary cell culture-based
approaches desirable. Wild-type renal cells have been charac-
terized extensively, but considerable limitations concerning
the genetic tractability of cultured cells have confounded mo-
lecular studies: the majority of isolated primary cells are het-
erogenous and have a finite replicative capacity; the genera-
tion of immortalized, differentiated renal epithelial cells from
patients or mouse models has proven difficult; murine embry-
onic fibroblasts (MEFs) from genetically modified mice lack
the epithelial characteristics of renal tubular cells; and the
physiological relevance of heterologous expression systems
has been questioned [9]. We therefore reasoned that the genet-
ic manipulation of endogenously expressed proteins in differ-
entiated renal epithelial cell lines may accelerate reaching
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novel insights into renal function. Indeed, genome edited renal
epithelial cells have been successfully used to study renal
epithelial physiology [e.g. 26, 29]. However, the practical im-
plementation of required genome engineering technologies
has been challenging for many laboratories. Thus, we provide
a step-by-step protocol for efficient genome editing of differ-
entiated renal epithelial and pluripotent cell types using
TALEN [3, 5, 18] and CRISPR [7, 14, 17, 24] technology to
generate targeted alleles within a short time-frame of 10weeks
at reasonable costs.
Methods
Genome editing of MDCK, mIMCD3, and mES cells—See
Supplementary Methods for step-by-step protocols.
Molecular biology
Mouse Pkd1 and human PKD2 cDNA have been described
previously [11]. All DNA constructs were validated by Sanger
sequencing. Oligonucleotides for genotyping PCRs are listed
in Supplementary Table 3 and Supplementary Table 4.
Cell transduction
Constitutive gene expression was achieved by pLXSN-
mediated (Clontech) retroviral transduction.
RNA isolation and reverse transcription polymerase chain
reaction
mRNA of a confluent 35 mm cell culture dish was isolated
(RNeasy Plus Mini Kit, Qiagen) and reversely transcribed to
complementary DNA (One Step RT-PCR Kit, Qiagen) ac-
cording to the manufacturer ’s protocols [1 , 6] .
Oligonucleotides for RT-PCRs are listed in Supplementary
Table 5.
Antibodies
Mouse anti-beta-Actin (Clone AC-15; Sigma-Aldrich), goat
anti-TRPP2 (G-20; Santa Cruz Biotechnology), mouse anti-
Polycystin-1 (7E12; Santa Cruz Biotechnology), chicken anti-
GFP (ab13970; Abcam), mouse anti-Flag M2 (clone M2;
Sigma-Aldrich), rabbit anti-V5 epitope tag (Merck
Millipore), and mouse anti-V5-Tag (Clone SV5-Pk1; Bio-
Rad) antibodies were obtained commercially. Mouse anti-
TRPP2698–799 antibodies have been described previously
[12, 13]. Western blot detection was performed using an anti-
mouse (Dako) horse-radish peroxidase-coupled secondary anti-
body. Antigens were visualized by immunofluorescence using
secondary goat anti-chicken Alexa Fluor 488 (Thermo Fisher
Scientific).
Protein isolation, SDS-PAGE, Western blot and ECL
detection
Cells were harvested 5 days after epithelial confluency.
Proteins were isolated and processed as described previously
[12, 13]. Chemiluminescence was detected by either a 16-bit
ChemoCam system (Intas) or by Super RX film (Fujifilm).
Immunofluorescence staining of cells
Indirect immunofluorescence staining of cells has been de-
scribed previously [12]. Cells were fixed by paraformalde-
hyde (Electron Microscopy Sciences). Primary (GFP, 1:2′
000) and secondary antibodies (1:1′000) were diluted in
PBS. F-actin was stained by Alexa Fluor 568 Phalloidin
(A12380, Thermo Fisher Scientific). DNAwas probed using
DAPI (Sigma-Aldrich). Bright-field images were recorded
using an Axio Observer microscope (Zeiss).
Results
To date, American Type Culture Collection lists 21 mamma-
lian renal epithelial cell lines (www.atcc.org). Of those,
Madin-Darby Canine Kidney (MDCK) cells and mouse
Inner Medullary Collecting Duct 3 (mIMCD3) cells are most
widely used to study renal epithelial biology (≥ 5′000 entries
on www.ncbi.nlm.nih.gov) [8, 22]. Both cell lines are
phenotypica l ly s table and reta in core epi thel ia l
characteristics, including apico-basolateral polarity, directed









Fig. 1 MDCK and mIMCD3 cells are highly differentiated renal epithelial
cells. aMDCKand bmIMCD3 cells stained for acetylated tubulin (aTub) to
mark primary cilia (white arrows) and ZO1 to visualize tight junctions as
markers for epithelial cell differentiation. Scale bars = 20 μm
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junctions in 2D and 3D culture (Fig. 1) [4, 10]. Furthermore,
cells proliferate rapidly and are suitable for biochemical, phys-
iological, and imaging-based experiments as well as high
throughput screening.
Genome editing in renal epithelial cells
To take advantage of well-characterized cell lines, we have
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Fig. 2 Genome editing of MDCK and mIMCD3 renal epithelial cells. a
Here, we provide a practical guide to generate genetically modified renal
epithelial cell culture models. Genome editing requires transfection of
programmable sequence-specific nucleases to induce DNA double strand
breaks (iDSB) [15, 21]. After PCR-based testing for genome editing
efficacy, cells are singularized in 96-well plates and clones are PCR-
screened for targeted alleles. Targeted clones (−/−) are selected and val-
idated by independent methods. d days,WBWestern blot, IF immunoflu-
orescence. See Supplementary Methods for a step-by-step protocol. b
Nuclease-induced DSBs are repaired by non-homologous end joining
(NHEJ) or homology directed repair (HDR). Both mechanisms can be
exploited for genome editing [15, 21]. For example, if two DSBs are
induced, error prone NHEJ may skip the middle piece causing a deletion;
or, if two DSBs are induced and a targeting vector is provided, precise
HDR may incorporate exogenous sequence elements (here, a
Flag epitope tag for biochemical protein detection and isolation) into
the genome. c Repeated transfection of cells increases the proportion of
transfected cells significantly. MDCK cells were repeatedly nucleofected
with GFP and fluorescent cells were counted using an automated cell
counter (N = 3; for each N we analyzed ≥2′000 cells). d In contrast to
MDCK cells, mIMCD3 cells are more sensitive to the transfection and
sorting procedure requiring higher cell numbers a priori (N = 5; wells
evaluated after single cell sorting / N ≥ 1′000). e To evaluate genome
editing efficacy in MDCK and mIMCD3 cells we targeted three genes
per cell line with both, TALEN and CRISPR technology. Target alleles
for TALENs and CRISPR were similar, but not identical, due to different
genomic binding site requirements.We aimed for large deletions (≥10 kb)
or HDR-mediated integrations of targeting vectors. Correctly targeted
heterozygous or homozygous clones were counted. Minor NHEJ-
mediated sequence changes were not considered. Significant genome
editing events were observed in 3.19% of MDCK and 6.62% of
mIMCD3 cells (N = 3 per cell line and genome editing technology; for
each N we analyzed between 90 and 1′101 clones). Data are presented as
means with s.e.m.
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generation of targeted alleles using genome editing technolo-
gy (Fig. 2a). During protocol optimization we have identified
several critical steps that facilitate gene targeting significantly.
Those include enhanced genome editing construct design for
rapid and reliable testing of editing efficacy, repeated transfec-
tions in intervals to increase targeting efficiencies, simplified
design of targeting vectors with or without selection cassettes
for homologous recombination, scalable clonal selection pro-
cedures, and streamlined screening approaches for positively
targeted clones (Fig. 2a–e and Supplementary Fig. 1a–f).
Details for the different experimental steps are discussed in
the Supplementary Methods. Our protocols provide a means-
tested basis to achieve genetically modified cell lines based on
non-homologous end joining (NHEJ) and homology directed
repair (HDR) (Fig. 2a–e, Supplementary Fig. 1a–f, and
Supplementary Methods).
Generation of cell culture models for ADPKD
The loss-of-function phenotypes of the ADPKD genes, polycys-
tic kidney disease 1 (PKD1) and PKD2, suggest that both genes
are part of an epithelial morphogenetic program to maintain
kidney structure [23, 27]. Yet, the molecular function of the
respective proteins, Polycystin-1 (PC1) and transient receptor
potential channel Polycystin-2 (TRPP2), has remained elusive
[2]. To demonstrate the versatility of our genome editing ap-
proach, we have established multiple novel cell lines for the
study of ADPKD by introducing targeted mutations into
PKD1 and PKD2 (Supplementary Table 1–4): (1) deletions of
PKD genes (Fig. 3a–d); (2) rescues of polycystin expression
(Fig. 4a, b); (3) generation of cell lines incorporating multiple
allelic features (Fig. 4c, d); and (4) introduction of epitope tags
into the Pkd1 genomic locus by homologous recombination
(Fig. 5a–d). The introduction of epitope tags into the PKD1
locus exemplifies the power of genome editing. Affinity purifi-
cation of PC1 is notoriously difficult (Fig. 5b). HA- and Myc-
tagged PKD1 alleles have been described previously, but purifi-
cation of sufficient amounts of native PC1 protein for mass
spectrometry-based proteomics has not been reported [30].
Here, we show that Flag epitope-tagged native PC1 can be pu-
rified with high affinity facilitating reliable detection by mass
spectrometry (Fig. 5b and Supplementary Table 6).
Furthermore, we confirm that endogenous PC1 and TRPP2
co-immunoprecipitate using a V5 epitope-tagged PC1
(Fig. 5d) [20, 28].
Translation of validated alleles to mouse models
We have shown that genetically engineered cells provide
valuable tools to complement in vivo models. Equally
useful, however, is the inverse approach: utilization of
tissue-specific cell culture models for functional valida-
tion of genetically engineered alleles before generation
of respective mouse models. Even though the generation
of genetically engineered mice is continuously improving,



























































Fig. 3 Genome editing-based
generation of ADPKD cell culture
models. Pkd1 (a, c) and Pkd2
(b, d) were deleted in mIMCD3
(a, b) and MDCK (c, d) cells.
Loss of ADPKD genes was
validated by genome sequencing
(Supplementary Table 1),
non-existence of respective
mRNA and/or absence of
polycystin proteins. Shown are
ADPKD gene structures with
respective exons (blue), location
of iDSB (red), size of genomic
deletion, RT-PCR, and Western
blot experiments validating
genomic knock-out of ADPKD
genes. We were not able to detect
endogenous PC1 protein in
MDCK cells. 36b4, Gapdh, and
Hprt1 served as positive controls
for RT-PCR; beta-Actin as
loading control for Western blot.
IP immunoprecipitation
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procedure. Genome editing has been used to generate mu-
tant alleles in mice [e.g. 25, 31]. Here, we propose that
testing of alleles in differentiated cells may help to facil-
itate the generation of complex genetic mouse models.
One example of this application is the addition of fluores-
cent tags to proteins of interest. Ideally, the function of
such engineered fusion proteins should be validated be-
fore generation of the respective mouse line. As a proof of
principle, we have generated a fluorescently tagged allele
of the basal lamina component, Laminin subunit alpha 5
(Lama5). Basal lamina biogenesis is a core epithelial
function, but its visualization in vivo has been difficult.
The generation of fluorescent laminin fusion proteins
showing sufficient brightness and proper localization to
the basal lamina has been particularly challenging. To
visualize basal lamina, we genetically fused eGFP to the
3′-end of the Lama5 coding sequence (Fig. 6a and
Supplementary Figure 2a–d). Resulting mIMCD3 cells
express a fluorescent LAMA5 (LAMA5GFP) that can be
studied in 3D culture (Fig. 6b, c) [10]. Obviously, a
complementing in vivo system is likely to provide addi-
tional insights. The C57BL/6J mouse origin of mIMCD3
cells, i.e. their isogenic status to commonly used mESCs,
is key to the direct transferability into mouse models [22].
Accordingly, we applied the mIMCD3-validated genome
editing constructs to the Lama5 locus in mESCs.
Comparable targeting efficiencies (mIMCD3 = 55%;
mESCs = 50%) suggest that genomic alterations in
mESCs can be readily tested in mIMCD3 cells and suc-
cessively used for the establishment of novel mouse al-
leles (Fig. 6a–e).
Discussion
Programmable sequence-specific nucleases are highly ef-
ficient genome editing tools in MDCK, mIMCD3, and


































































Fig. 4 Combinatorial genetics complement the study of ADPKD
in vitro. In the study of biological processes, it is often desirable to be
able to genetically recombine specific sequence elements or manipulate
multiple genes simultaneously. We used genome editing-based combina-
torial genetics to generate ADPKD cell culture models beyond loss of
ADPKD gene function. Proper controls are essential to help ensure suc-
cess in every experiment; therefore, we genetically rescued Pkd1 (Fig. 2a)
and Pkd2 (Fig. 2d) deficiency using retrovirus-mediated transduction to
generate a mIMCD3 Pkd1−/−; Tg(Pkd1) and b MDCK Pkd2−/−;
Tg(PKD2) cells. Polycystin expression in these cell lines was validated
by Western blot. Rescue cell lines may help to ensure that observed
effects are due to knock-out of PKD genes. Knock-out of both ADPKD
genes, on the other hand, fully inactivates the polycystin signaling mod-
ule providing a maximal ADPKD model. c Loss of PKD genes in
mIMCD3 cells (Pkd-dKO) was shown by RT-PCR and Western blot.
(d) Virus transduction-mediated rescue of polycystin expression was
demonstrated by Western blot (Pkd-dKORescue). 36b4 served as positive
controls for RT-PCR; beta-Actin as loading control for Western blot. IP
immunoprecipitation, Tg transgene
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complement RNAi-based approaches, which are limited to
inhibition of post-transcriptional gene expression. The
modular nature of TALEN and CRISPR systems facili-
tates additional applications other than genome editing,
including selective labeling of nucleotide sequences, tran-
scriptional regulation, or alteration of epigenetic DNA
modifications [15, 21]. Similar to genome editing all these
applications are based on the sequence-specific targeting
of enzymes by the nucleotide-binding TALEN or CRISPR
construct. Therefore, although their sequence specificity
has been shown to be fairly high—especially in compar-
ison to RNAi—experimental designs based on TALEN or
CRISPR constructs have to control for putative off-target
effects [16, 19]. For genome editing-mediated generation
of cellular loss-of-function models, we suggest the com-
bination of a complete gene excision with subsequent
gene rescue (Fig. 4a–d). NHEJ-mediated short sequence
alterations are commonly used, but may be difficult to
interpret due to alternative splicing or stop codon read-
through, which may result in residual protein function.
In contrast, complete gene excision generates definite null
alleles with complete loss of protein function (Fig. 3 and
Supplementary Fig. 1c). Rescue of the gene excision by
reintroduction of the respective coding sequence can ac-
curately distinguish, whether an observed phenotype is
gene-dependent or caused by deletion of additional regu-
latory sequences in the mutant background. HDR-
mediated genome editing, furthermore, facilitates the
study of physiological functions of endogenous proteins
(Fig. 5a–d and Fig. 6a–e). Targeted mutation or introduc-
tion of tags, for example, may elucidate the molecular












































Fig. 5 Targeted epitope tagging of endogenous PC1 facilitates
biochemical and mass spectrometry-based analysis. PC1 protein detec-
tion and purification is particularly difficult problem in ADPKD research
severely constraining biochemical analysis of polycystin signaling. To
overcome this issue, we introduced well-established exogenous epitope
tags into the endogenous PC1 protein. a Introduction of three Flag epitope
tags into the mouse Pkd1 genomic locus by homologous recombination
(mIMCD3 Pkd1Flag) was tested by respective size shift of genomic PCR
(Supplementary Fig. 1e) . b Endogenous PC1Fla g can be
immunoprecipitated efficiently with anti-Flag M2 antibodies facilitating
mass spectrometry-based analysis (Supplementary Table 6). On the other
hand, IP of PC1 using a specific antibody was inefficient. c Similarly,
introduction of two V5 epitope tags into the mouse Pkd1 genomic locus
(mIMCD3 Pkd1V5) was validated by PCR (Supplementary Fig. 1f). AV5
epitope tag-independent Pkd1 PCR served as positive control (oligonu-
cleotides mPkd1-Flag_1 and mPkd1-Flag_2). d Endogenous PC1V5 can
be precipitated and detected with rabbit anti-V5 and mouse anti-V5 anti-
bodies, respectively. Native TRPP2 co-precipitates with PC1V5. IP
immunoprecipitation
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Conclusions
Here, we present an easily applicable workflow for efficient
genetic manipulation of differentiated renal epithelial cell
lines. The development of genetically engineered MDCK
and mIMCD3 cells with isogenic controls provides novel ver-
satile tools to study renal biology under well-controlled con-
ditions. Importantly, the described protocols can be readily
adjusted to other cell types, including mESCs for the efficient
generation of novel mouse models. In addition, we show that
complex genetic alterations can be tested in differentiated cell
types before the corresponding mouse strains are established.
Taken together, we anticipate that described protocols will
contribute to a broader use of genome editing technology for
functional studies of renal epithelial cells as well as other cell
types in health and disease.
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Fig. 6 Testing of functional
alleles in mIMCD3 cells and
transfer into mESCs. a Gene
structure of mouse Lama5 with
exons as blue bars. TALENs were
directed to induce two double
strand breaks (iDSB, red bars) in
the last coding exon (# 79) of the
Lama5 gene leading to a deletion
of 220 bp in proximity to the
terminator TGA-codon. TALEN-
efficiency was tested in mIMCD3
cells generating a 568 bp deletion
band (wild-type = 788 bp). Using
a 2.8 kb targeting construct
mIMCD3 and mES cells were
targeted by homologous
recombination to genetically fuse
an eGFP cDNA to the 3′-end of
the Lama5 coding sequence
(Supplementary Figure 2a-d).
Due to the C57BL/6J mouse
origin of mIMCD3 cells, the same
TALENs and targeting vector can
be applied to mESCs. b, cWild-
type (b) and targeted (c)
mIMCD3 cells were grown in 3D
culture to form spheroids.
Targeted Lama5GFP mIMCD3
cells express a green fluorescent
basal lamina. d, e Similarly,
embryoid bodies, derived from
genetically engineered mESCs
express a green fluorescent basal
lamina. These cells may be
injected into mouse blastocysts to
generate chimeric mice. Scale
bars = 100 μm
Pflugers Arch - Eur J Physiol (2017) 469:303–311 309
Natalia A. Martagón Calderón for expert technical assistance. Thomas
Lahaye and Toni Cathomen provided their TALEN Golden Gate assem-
bly kit. CRISPR/Cas9 plasmids were a gift from Feng Zhang. Funding
was awarded by the Deutsche Forschungsgemeinschaft to M.K. (KFO
201, CRC 152, and CRC 1140), to E.W.K. (KFO 201), and to S.J.A.
(CRC850, CRC 1140, and AR732/1-1); by the Excellence Initiative of
the German Federal and State Governments (GSC-4, Spemann Graduate
School); by the Else Kröner-Fresenius-Stiftung to E.W.K. (2011_A87);
A.V. (ERA-EDTA ALTF 84-2011); and F.B. (EMBO ALTF 927-2013).
Author contributions A.H., T.B., S.J.A., N.H., A.N., A.B., A.V. and
F.B. performed experiments. E.W.K. and S.J.A. made intellectual contri-
butions to experimental design and discussion. A.H. and M.K. designed
the study, A.H., S.J.A., and M.K. wrote and edited the manuscript.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Akamine R, Yamamoto T, Watanabe M, Yamazaki N, Kataoka M,
IshikawaM, Ooie T, Baba Y, Shinohara Y (2007) Usefulness of the
5’ region of the cDNA encoding acidic ribosomal phosphoprotein
P0 conserved among rats, mice, and humans as a standard probe for
gene expression analysis in different tissues and animal species. J
Biochem Biophys Methods 70:481–486
2. Antignac C, Calvet JP, Germino GG, Grantham JJ, Guay-Woodford
LM,Harris PC, Hildebrandt F, Peters DJ, Somlo S, Torres VE,Walz
G, Zhou J, Yu AS (2015) The future of polycystic kidney disease
research—as seen by the 12 Kaplan awardees. J Am Soc Nephrol:
JASN 26:2081–2095
3. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S,
Lahaye T, Nickstadt A, Bonas U (2009) Breaking the code of
DNA binding specificity of TAL-type III effectors. Science 326:
1509–1512
4. Boletta A, Qian F, Onuchic LF, Bhunia AK, Phakdeekitcharoen B,
Hanaoka K, Guggino W, Monaco L, Germino GG (2000)
Polycystin-1, the gene product of PKD1, induces resistance to ap-
optosis and spontaneous tubulogenesis inMDCK cells. Mol Cell 6:
1267–1273
5. Boller T, He SY (2009) Innate immunity in plants: an arms race
between pattern recognition receptors in plants and effectors in
microbial pathogens. Science 324:742–744
6. Brinkhof B, Spee B, Rothuizen J, Penning LC (2006) Development
and evaluation of canine reference genes for accurate quantification
of gene expression. Anal Biochem 356:36–43
7. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu
X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome
engineering using CRISPR/Cas systems. Science 339:819–823
8. Gaush CR, Hard WL, Smith TF (1966) Characterization of an
established line of canine kidney cells (MDCK). Proc Soc Exp
Biol Med 122:931–935
9. Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney
RI, Knezevic I, Lovell-Badge R, Masters JR, Meredith J, Stacey
GN, Thraves P, ViasM, Cancer Research UK (2014) Guidelines for
the use of cell lines in biomedical research. Br J Cancer 111:1021–
1046
10. Giles RH, Ajzenberg H, Jackson PK (2014) 3D spheroid model of
mIMCD3 cells for studying ciliopathies and renal epithelial disor-
ders. Nat Protoc 9:2725–2731
11. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L,
Sukhatme VP, Guggino WB, Germino GG (2000) Co-assembly of
polycystin-1 and -2 produces unique cation-permeable currents.
Nature 408:990–994
12. Hofherr A, Wagner C, Fedeles S, Somlo S, Kottgen M (2014) N-
glycosylation determines the abundance of the transient receptor
potential channel TRPP2. J Biol Chem 289:14854–14867
13. Hofherr A, Wagner CJ, Watnick T, Kottgen M (2016) Targeted
rescue of a polycystic kidney disease mutation by lysosomal inhi-
bition. Kidney Int 89:949–955
14. JinekM, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier
E (2012) A programmable dual-RNA-guided DNA endonuclease
in adaptive bacterial immunity. Science 337:816–821
15. Joung JK, Sander JD (2013) TALENs: a widely applicable technol-
ogy for targeted genome editing. Nat Rev Mol Cell Biol 14:49–55
16. Lin X, Ruan X, Anderson MG, McDowell JA, Kroeger PE, Fesik
SW, Shen Y (2005) siRNA-mediated off-target gene silencing trig-
gered by a 7 nt complementation. Nucleic Acids Res 33:4527–4535
17. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville
JE, Church GM (2013) RNA-guided human genome engineering
via Cas9. Science 339:823–826
18. Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X,
Paschon DE, Leung E, Hinkley SJ, Dulay GP, Hua KL,
Ankoudinova I, Cost GJ, Urnov FD, Zhang HS, Holmes MC,
Zhang L, Gregory PD, Rebar EJ (2011) ATALE nuclease architec-
ture for efficient genome editing. Nat Biotechnol 29:143–148
19. Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM,
Gregg A, Noggle S, Tessier-Lavigne M (2016) Efficient introduc-
tion of specific homozygous and heterozygous mutations using
CRISPR/Cas9. Nature 533:125–129
20. Qian F, Germino FJ, Cai Y, ZhangX, Somlo S, Germino GG (1997)
PKD1 interacts with PKD2 through a probable coiled-coil domain.
Nat Genet 16:179–183
21. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013)
Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8:
2281–2308
22. Rauchman MI, Nigam SK, Delpire E, Gullans SR (1993) An os-
motically tolerant inner medullary collecting duct cell line from an
SV40 transgenic mouse. Am J Phys 265:F416–F424
23. SemmoM, Kottgen M, Hofherr A (2014) The TRPP subfamily and
polycystin-1 proteins. Handb Exp Pharmacol 222:675–711
24. Shen B, Zhang W, Zhang J, Zhou J, Wang J, Chen L, Wang L,
Hodgkins A, Iyer V, Huang X, Skarnes WC (2014) Efficient ge-
nome modification by CRISPR-Cas9 nickase with minimal off-
target effects. Nat Methods 11:399–402
25. Singh P, Schimenti JC, Bolcun-Filas E (2015) A mouse geneticist’s
practical guide to CRISPR applications. Genetics 199:1–15
26. Tokuda S, Furuse M (2015) Claudin-2 knockout by TALEN-
mediated gene targeting in MDCK cells: claudin-2 independently
determines the leaky property of tight junctions in MDCK cells.
PLoS One 10:e0119869
27. Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant poly-
cystic kidney disease. Lancet 369:1287–1301
28. Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G (1997)
Homo- and heterodimeric interactions between the gene
products of PKD1 and PKD2. Proc Natl Acad Sci U S A
94:6965–6970
310 Pflugers Arch - Eur J Physiol (2017) 469:303–311
29. Van Itallie CM, Tietgens AJ, Krystofiak E, Kachar B, Anderson JM
(2015) A complex of ZO-1 and the BAR-domain protein TOCA-1
regulates actin assembly at the tight junction. Mol Biol Cell 26:
2769–2787
30. Wodarczyk C, Rowe I, Chiaravalli M, Pema M, Qian F, Boletta A
(2009) A novel mouse model reveals that polycystin-1 deficiency in
ependyma and choroid plexus results in dysfunctional cilia and
hydrocephalus. PLoS One 4:e7137
31. Zhang X, Liang P, Ding C, Zhang Z, Zhou J, Xie X, Huang R, Sun
Y, Sun H, Zhang J, Xu Y, Songyang Z, Huang J (2016) Efficient
production of Gene-Modified Mice using Staphylococcus aureus
Cas9. Sci Rep 6:32565
Pflugers Arch - Eur J Physiol (2017) 469:303–311 311
